These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 15894673)

  • 1. Insulin-like growth factor polymorphisms and colorectal cancer risk.
    Morimoto LM; Newcomb PA; White E; Bigler J; Potter JD
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1204-11. PubMed ID: 15894673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variation in plasma insulin-like growth factor-1 and insulin-like growth factor binding protein-3: genetic factors.
    Morimoto LM; Newcomb PA; White E; Bigler J; Potter JD
    Cancer Epidemiol Biomarkers Prev; 2005 Jun; 14(6):1394-401. PubMed ID: 15941947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations among IRS1, IRS2, IGF1, and IGFBP3 genetic polymorphisms and colorectal cancer.
    Slattery ML; Samowitz W; Curtin K; Ma KN; Hoffman M; Caan B; Neuhausen S
    Cancer Epidemiol Biomarkers Prev; 2004 Jul; 13(7):1206-14. PubMed ID: 15247132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of insulin-like growth factors system gene polymorphisms with the susceptibility and pathological development of hepatocellular carcinoma.
    Weng CJ; Hsieh YH; Tsai CM; Chu YH; Ueng KC; Liu YF; Yeh YH; Su SC; Chen YC; Chen MK; Yang SF
    Ann Surg Oncol; 2010 Jul; 17(7):1808-15. PubMed ID: 20119675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer.
    Krajcik RA; Borofsky ND; Massardo S; Orentreich N
    Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1566-73. PubMed ID: 12496045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlates of obesity in postmenopausal women with breast cancer: comparison of genetic, demographic, disease-related, life history and dietary factors.
    Wasserman L; Flatt SW; Natarajan L; Laughlin G; Matusalem M; Faerber S; Rock CL; Barrett-Connor E; Pierce JP
    Int J Obes Relat Metab Disord; 2004 Jan; 28(1):49-56. PubMed ID: 14557830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is there an association between variants in candidate insulin pathway genes IGF-I, IGFBP-3, INSR, and IRS2 and risk of colorectal cancer in the Iranian population?
    Karimi K; Mahmoudi T; Karimi N; Dolatmoradi H; Arkani M; Farahani H; Vahedi M; Parsimehr E; Dabiri R; Nobakht H; Asadi A; Zali MR
    Asian Pac J Cancer Prev; 2013; 14(9):5011-6. PubMed ID: 24175768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IGF-I and IGFBP-3 polymorphisms and risk of prostate cancer.
    Friedrichsen DM; Hawley S; Shu J; Humphrey M; Sabacan L; Iwasaki L; Etzioni R; Ostrander EA; Stanford JL
    Prostate; 2005 Sep; 65(1):44-51. PubMed ID: 15800934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum insulin-like growth factors, insulin-like growth factor binding proteins, and breast cancer risk in postmenopausal women.
    Grønbaek H; Flyvbjerg A; Mellemkjaer L; Tjønneland A; Christensen J; Sørensen HT; Overvad K
    Cancer Epidemiol Biomarkers Prev; 2004 Nov; 13(11 Pt 1):1759-64. PubMed ID: 15533904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variation in plasma insulin-like growth factor-1 and insulin-like growth factor binding protein-3: personal and lifestyle factors (United States).
    Morimoto LM; Newcomb PA; White E; Bigler J; Potter JD
    Cancer Causes Control; 2005 Oct; 16(8):917-27. PubMed ID: 16132801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer risk factors associated with insulin-like growth factor (IGF)-I and IGF-binding protein-3 levels in healthy women: effect modification by menopausal status.
    Barnes BB; Chang-Claude J; Flesch-Janys D; Kinscherf R; Schmidt M; Slanger T; Bonaterra G; Steindorf K
    Cancer Causes Control; 2009 Dec; 20(10):1985-96. PubMed ID: 19597750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variants and traits related to insulin-like growth factor-I and insulin resistance and their interaction with lifestyles on postmenopausal colorectal cancer risk.
    Jung SY; Rohan T; Strickler H; Bea J; Zhang ZF; Ho G; Crandall C
    PLoS One; 2017; 12(10):e0186296. PubMed ID: 29023587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new single nucleotide polymorphism in the insulin-like growth factor I regulatory region associates with colorectal cancer risk in singapore chinese.
    Wong HL; Delellis K; Probst-Hensch N; Koh WP; Van Den Berg D; Lee HP; Yu MC; Ingles SA
    Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):144-51. PubMed ID: 15668488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IGF1 CA repeat polymorphisms, lifestyle factors and breast cancer risk in the Long Island Breast Cancer Study Project.
    Cleveland RJ; Gammon MD; Edmiston SN; Teitelbaum SL; Britton JA; Terry MB; Eng SM; Neugut AI; Santella RM; Conway K
    Carcinogenesis; 2006 Apr; 27(4):758-65. PubMed ID: 16332723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk.
    Schernhammer ES; Holly JM; Pollak MN; Hankinson SE
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):699-704. PubMed ID: 15767352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen receptor-β gene polymorphism and colorectal cancer risk: effect modified by body mass index and isoflavone intake.
    Honma N; Yamamoto K; Ohnaka K; Morita M; Toyomura K; Kono S; Muramatsu M; Arai T; Ueki T; Tanaka M; Kakeji Y; Maehara Y; Okamura T; Ikejiri K; Futami K; Maekawa T; Yasunami Y; Takenaka K; Ichimiya H; Terasaka R
    Int J Cancer; 2013 Feb; 132(4):951-8. PubMed ID: 22729816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Energy balance, insulin-related genes and risk of colon and rectal cancer.
    Slattery ML; Murtaugh M; Caan B; Ma KN; Neuhausen S; Samowitz W
    Int J Cancer; 2005 May; 115(1):148-54. PubMed ID: 15688407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Association of insulin, insulin-like growth factor and insulin-like growth factor binding proteins with the risk of colorectal cancer].
    Jiang B; Liu DB; Zhang X; DU LL; Han CZ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2009 May; 12(3):264-8. PubMed ID: 19434535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone-binding protein is directly and IGFBP-3 is inversely associated with risk of female breast cancer.
    Pazaitou-Panayiotou K; Kelesidis T; Kelesidis I; Kaprara A; Blakeman J; Vainas I; Mpousoulegas A; Williams CJ; Mantzoros C
    Eur J Endocrinol; 2007 Feb; 156(2):187-94. PubMed ID: 17287408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate cancer risk in relation to selected genetic polymorphisms in insulin-like growth factor-I, insulin-like growth factor binding protein-3, and insulin-like growth factor-I receptor.
    Chen C; Freeman R; Voigt LF; Fitzpatrick A; Plymate SR; Weiss NS
    Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2461-6. PubMed ID: 17164371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.